Omega Healthcare Q3 2024 Earnings Report
Key Takeaways
Omega Healthcare Investors, Inc. announced its Q3 2024 results, featuring a net income of $115 million, or $0.42 per common share, and adjusted Funds From Operations (FFO) of $203 million, or $0.74 per common share. The company completed $440 million in new investments during the quarter and increased its full-year AFFO guidance to $2.84 to $2.86 per share.
Net income for the quarter was $115 million, or $0.42 per common share.
Nareit Funds From Operations (FFO) for the quarter was $196 million, or $0.71 per common share.
Adjusted Funds From Operations (AFFO) for the quarter was $203 million, or $0.74 per common share.
Completed $440 million in new investments in Q3, including real estate acquisitions and loans.
Omega Healthcare
Omega Healthcare
Omega Healthcare Revenue by Segment
Forward Guidance
The Company increased its expected 2024 Adjusted FFO range to be between $2.84 to $2.86 per diluted share from the previous range of $2.78 to $2.84 per diluted share.
Positive Outlook
- Includes the annual impact of $834 million in new investments completed through October 2024.
- Includes $31 million in asset sales related to a portion of the $76 million in facilities classified as held for sale.
- Considers fourth quarter G&A expense of approximately $11.5 million to $13.5 million.
- Assumes no material changes in market interest rates.
- Assumes no additional operators are placed on a cash-basis for revenue recognition.
Challenges Ahead
- Excludes any additional acquisitions and asset sales.
- Excludes certain revenue and expense items.
- Excludes interest refinancing expenses.
- Excludes acquisition costs.
- Excludes capital market activity and additional provisions for credit losses, if any.